Form 4: Xtant Medical Director Awarded 158,228 DSUs

Xtant Medical Holdings, Inc. director Abhinav Jain received a deferred stock unit award of 158,228 shares, vesting in November 2026.

Summary

• Abhinav Jain, a Director of Xtant Medical Holdings, Inc. (XTNT), was granted 158,228 shares of Common Stock.
• The shares were awarded as Deferred Stock Units (DSUs) under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan.
• The DSUs will vest on November 15, 2026, contingent upon Mr. Jain remaining a director through that date.
• Settlement of the vested shares will be deferred to a later date as per the DSU award agreement.
• Each DSU represents a contingent right to receive one share of the Issuer's common stock.
• Following this transaction, Mr. Jain beneficially owns 158,228 shares, all of which are issuable upon settlement of these DSUs.

Sentiment

Score: 6

Explanation: The filing indicates a routine equity compensation award to a director, which is generally a positive sign of aligning management interests with shareholders, though it doesn't provide broader financial or operational news.

Positives

• The award aligns the director's interests with those of shareholders by increasing his equity stake in the company.
• The grant is part of an established equity incentive plan, indicating a structured approach to executive and director compensation.

Risks

• The vesting of the 158,228 shares is conditioned upon the reporting person remaining a director of Xtant through November 15, 2026.

Future Outlook

The 158,228 Deferred Stock Units are scheduled to vest on November 15, 2026, provided the reporting person continues to serve as a director. The actual settlement of these vested shares will occur at a later, unspecified date according to the DSU award agreement.

Industry Context

This Form 4 filing details a routine insider compensation event, specifically an equity award to a director. Such awards are common practice across industries to incentivize long-term commitment and align management interests with shareholder value, particularly in the medical technology sector where long-term strategic development is key.

Corporate Governance

Stakeholder Impact

• Shareholders: The award aligns the director's financial interests with long-term shareholder value creation, as the shares vest based on continued service and represent future equity ownership.
• Employees: While not directly impacting employees, the use of an equity incentive plan for directors sets a precedent for compensation structures within the company.

Next Steps

• The 158,228 Deferred Stock Units are expected to vest on November 15, 2026, subject to the director's continued service.
• Settlement of the vested shares will occur at a later date as per the DSU award agreement.

Key Dates

Keywords

Xtant Medical Holdings, XTNT, Abhinav Jain, Deferred Stock Units, DSU, Equity Incentive Plan, Insider Transaction, Form 4, Director Compensation, Stock Award